BF Biosciences Limited (PSX:BFBIO)
Pakistan
· Delayed Price · Currency is PKR 141.54
-4.82 (-3.29%)
At close: Apr 28, 2026
BF Biosciences Cash Flow Statement
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2019 |
| Net Income | 591.76 | 447.15 | 385.41 | 149.05 | 306.98 | 607.99 | Upgrade
|
| Depreciation & Amortization | 268.99 | 191.92 | 35.57 | 33.78 | 28 | 23 | Upgrade
|
| Other Amortization | 1.69 | 1.69 | 0.55 | 0.55 | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -4.36 | -2.79 | -2.13 | -1.06 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -40.17 | -27.3 | -0.21 | -8.93 | - | - | Upgrade
|
| Other Operating Activities | 166.68 | 44.33 | 305.49 | 32.12 | -156.98 | -60.99 | Upgrade
|
| Change in Accounts Receivable | -269.06 | 20.37 | -110.82 | -41.1 | - | - | Upgrade
|
| Change in Inventory | -889.76 | -846.4 | -41.57 | -445.69 | - | - | Upgrade
|
| Change in Accounts Payable | 461.84 | 472.43 | 196.75 | -5.94 | - | - | Upgrade
|
| Change in Unearned Revenue | -2.62 | -5.27 | 19.75 | -17.78 | - | - | Upgrade
|
| Change in Other Net Operating Assets | -14.94 | 3.66 | -124.09 | 108.94 | - | - | Upgrade
|
| Operating Cash Flow | 297.3 | 299.79 | 664.7 | -196.07 | 178 | 570 | Upgrade
|
| Operating Cash Flow Growth | - | -54.90% | - | - | -68.77% | - | Upgrade
|
| Capital Expenditures | -513.91 | -329.49 | -143.13 | -1,968 | -1,130 | -941 | Upgrade
|
| Sale of Property, Plant & Equipment | 8.25 | 3.86 | 4.4 | 1.06 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | 5.12 | - | - | -1.66 | - | - | Upgrade
|
| Investment in Securities | 485.9 | -1,100 | 108.58 | 1,161 | - | - | Upgrade
|
| Other Investing Activities | 78.29 | 91 | 16.34 | 83.4 | -333 | -399 | Upgrade
|
| Investing Cash Flow | 63.66 | -1,335 | -13.81 | -724.44 | -1,463 | -1,340 | Upgrade
|
| Long-Term Debt Issued | - | 93.55 | - | 811.02 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -436.19 | -321.36 | -50.5 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -483.8 | -342.64 | -321.36 | 760.52 | - | - | Upgrade
|
| Issuance of Common Stock | - | 1,855 | - | - | - | - | Upgrade
|
| Other Financing Activities | -73.56 | -112.25 | -161.52 | -120.28 | 925 | 1,162 | Upgrade
|
| Financing Cash Flow | -557.36 | 1,400 | -482.88 | 640.24 | 925 | 1,162 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | 1 | 1 | Upgrade
|
| Net Cash Flow | -196.4 | 365.04 | 168.02 | -280.27 | -359 | 393 | Upgrade
|
| Free Cash Flow | -216.61 | -29.71 | 521.57 | -2,164 | -952 | -371 | Upgrade
|
| Free Cash Flow Margin | -2.44% | -0.51% | 14.26% | -119.61% | -62.60% | -21.14% | Upgrade
|
| Free Cash Flow Per Share | -2.45 | -0.37 | 8.23 | -34.17 | -15.03 | -5.86 | Upgrade
|
| Cash Interest Paid | 112.25 | 112.25 | 161.52 | 120.28 | - | - | Upgrade
|
| Cash Income Tax Paid | 279.05 | 279.05 | 51.39 | 73.4 | - | - | Upgrade
|
| Levered Free Cash Flow | -465.64 | -255.5 | 313.25 | -2,306 | -834 | -670.45 | Upgrade
|
| Unlevered Free Cash Flow | -393.53 | -183.39 | 401.52 | -2,306 | -792.99 | -654.66 | Upgrade
|
| Change in Working Capital | -714.55 | -355.21 | -59.98 | -401.58 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.